Écrit par WHO | 24 Décembre 2016

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year.

The vaccine, called rVSV-ZEBOV, was studied in a trial involving 11,841...

Écrit par University of Warwick | 21 Décembre 2016

Elimination of elephantiasis disease lymphatic filariasis assisted by University of Warwick research About one billion people in 54 countries live with threat of disease, which disables victimsMathematical model works out the potential impact of treating and preventing disease with three drugs



A disabling parasitic disease which causes elephantiasis, and threatens around one billion people...

Écrit par SPF | 21 Décembre 2016

Les points clés

Epidémie de grippe dans 9 des 13 régions en métropole.
Virus A(H3N2) dominant.
Impact important chez les personnes âgées.

Écrit par WHO | 19 Décembre 2016

16 December 2016, GENEVA - The World Health Organization is calling for medical evacuation of the sick and injured from east Aleppo to be resumed as quickly as possible. Almost 200 patients were safely transferred to hospitals in western rural Aleppo, Idlib and Turkey before all evacuations were aborted this morning, leaving many more in need of medical care stranded.

“The medical...